Modeling the Impact of Simulated Educational Interventions on the Use and Abuse of Pharmaceutical Opioids in the United States

Abstract

Three educational interventions were simulated in a system dynamics model of the medical use, trafficking, and nonmedical use of pharmaceutical opioids. The study relied on secondary data obtained in the literature for the period of 1995 to 2008 as well as expert panel recommendations regarding model parameters and structure. The behavior of the resulting systems-level model was tested for fit against reference behavior data. After the base model was tested, logic to represent three educational interventions was added and the impact of each intervention on simulated overdose deaths was evaluated over a 7-year evaluation period, 2008 to 2015. Principal findings were that a prescriber education intervention not only reduced total overdose deaths in the model but also reduced the total number of persons who receive opioid analgesic therapy, medical user education not only reduced overdose deaths among medical users but also resulted in increased deaths from nonmedical use, and a “popularity” intervention sharply reduced overdose deaths among nonmedical users while having no effect on medical use. System dynamics modeling shows promise for evaluating potential interventions to ameliorate the adverse outcomes associated with the complex system surrounding the use of opioid analgesics to treat pain.

Keywords

alcohol and substance abuse dynamic modeling modeling and simulation nonlinear dynamics substance use systems science

Get full access to this article

View all access options for this article.

References

American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV (4th ed.). Washington, DC: Author.

Cavana

R. Y.

Tobias

(2008). Integrative system dynamics: Analysis of policy options for tobacco control in New Zealand. Systems Research and Behavioral Science, 25, 675-694.

Chou

Ballantyne

J. C.

Fanciullo

G. J.

Fine

P. G.

Miaskowski

(2009). Research gaps on the use of opioids for chronic noncancer pain: Findings from a review of the evidence for an American pain society and American academy of pain medicine clinical practice guideline. Journal of Pain, 10, 147-159.

Cicero

T. J.

Surratt

Inciardi

J. A.

Munoz

(2007). Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiology and Drug Safety, 16, 827-840.

Collett

B. J.

(2001). Chronic opioid therapy for non-cancer pain. British Journal of Anesthesia, 87, 133-143.

Colliver

J. D.

Kroutil

L. A.

Dai

Gfroerer

J. C.

(2006). Misuse of prescription drugs: Data from the 2002, 2003, and 2004 National Surveys on Drug Use and Health (DHHS Publication No. SMA 06-4192; Analytic Series A-28). Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies.

Compton

W. M.

Volkow

N. D.

(2006). Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug and Alcohol Dependence, 81, 103-107.

Degenhardt

Hall

Warner-Smith

Lynskey

(2004). Illicit drug use. In Ezzati

Lopez

A. D.

Rodgers

Murray

C. J. L.

(Eds.), Comparative quantification of health risks: Global and regional burden of disease attributable to selected major risk factors (Vol. 1, pp. 1109-1175). Geneva, Switzerland: World Health Organization.

Dunn

K. M.

Saunders

K. W.

Rutter

C. M.

Banta-Green

C. J.

Merrill

J. O.

Sullivan

M. D.

Von Korff

(2010). Opioid prescriptions for chronic pain and overdose. Annals of Internal Medicine, 152, 85-92.

10.

Fishbain

D. A.

Cole

Lewis

Rosomoff

H. L.

Rosomoff

R. S.

(2008). What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and or aberrant drug-related behaviors? A structured, evidence-based review. Pain Medicine, 9, 444-459.

11.

Fischer

Brissette

Brochu

Bruneau

el-Guebaly

Noël

Baliunas

(2004). Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. Canadian Medical Association Journal, 171, 235-239.

12.

Fishman

S. M.

Papazian

J. S.

Gonzalez

Riches

P. S.

Gilson

(2004). Regulating opioid prescribing through prescription monitoring programs: Balancing drug diversion and treatment of pain. Pain Medicine, 5, 309-324.

13.

Food and Drug Administration. (2008). Federal register: Identification of drugs deemed to have REMS. Federal Register, 73, 16313-16314.

14.

Food and Drug Administration. (2012). Risk evaluation and mitigation strategy (REMS) for extended-release and long-acting opioids. Retrieved from http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm163647.htm

15.

Furlan

A. D.

Sandoval

J. A.

Mailis-Gagnon

Tunks

(2006). Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. Canadian Medical Association Journal, 174, 1589-1594.

16.

Governale

(2007). Methadone utilization in the U.S., 2002-2006 [PowerPoint presentation]. Retrieved from http://www.docstoc.com/docs/141156348/Methadone-Utilization-in-the-US_-2002-2006

17.

Governale

(2008a). Outpatient drug utilization trends for extended release morphine products [PowerPoint presentation]. Retrieved from http://www.fda.gov/ohrms/DOCKETS/ac/08/slides/2008-4395s2-04-FDA-Governale.ppt

18.

Governale

(2008b). Outpatient drug utilization trends for oxycodone products [PowerPoint presentation]. Retrieved from http://www.fda.gov/ohrms/dockets/ac/08/slides/2008-4395s1-04-FDA-Governale.ppt

19.

Gureje

Simon

G. E.

Von Korff

(2001). A cross-national study of the course of persistent pain in primary care. Pain, 92, 195-200.

20.

Hall

A. J.

Logan

J. E.

Toblin

R. L.

Kaplan

J. A.

Kraner

J. C.

Bixler

Paulozzi

L. J.

(2008). Patterns of abuse among unintentional pharmaceutical overdose fatalities. Journal of the American Medical Association, 300, 2613-2620.

21.

Hardt

Jacobsen

Goldberg

Nickel

Buchwald

(2008). Prevalence of chronic pain in a representative sample in the United States. Pain Medicine, 9, 803-812.

22.

Højsted

Sjøgren

(2007). Addiction to opioids in chronic pain patients: A literature review. European Journal of Pain, 11, 490-518.

23.

Homer

J. B.

(1993). Projecting the impact of law enforcement on cocaine prevalence: A system dynamics approach. Journal of Drug Issues, 23, 281-295.

24.

Hser

Hoffman

Grella

C. E.

Anglis

M. D.

(2001). A 33-year follow-up of narcotics addicts. Archives of General Psychiatry, 58, 503-508.

25.

Johnston

L. D.

O’Malley

P. M.

Bachman

J. G.

Schulenberg

J. E.

(2007). Overall illicit drug use by American teens continues gradual decline in 2007. Ann Arbor: University of Michigan News Service. Retrieved from www.monitoringthefuture.org

26.

Jones

Homer

Murphy

Essein

Milstein

Seville

(2006). Understanding diabetes population dynamics through simulation modeling and experimentation. American Journal of Public Health, 96, 488-494.

27.

Joranson

D. E.

Gilson

A. M.

Dahl

J. L.

Haddox

J. D.

(2002). Pain management, controlled substances, and state medical board policy. Journal of Pain and Symptom Management, 23, 138-147.

28.

Lee

McCarty

Haddox

J. D.

Fitzgerald

Wakeland

Webster

(2010). Non-prescribed use of Vicodin^® and OxyContin^® among U.S. youth. Paper presented at College on Problems of Drug Dependence, 72nd Annual Scientific Meeting, Scottsdale, AZ.

29.

Mack

A. H.

Frances

R. J.

(2003). Substance-related disorders. FOCUS, 1, 125-146.

30.

Manchikanti

Cash

Damron

K. S.

Manchukonda

Pampati

McManus

C. D.

(2006). Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables. Pain Physician, 9, 215-226.

31.

Milstein

Homer

Hirsch

(2010). Analyzing national health reform strategies with a dynamic simulation model. American Journal of Public Health, 100, 811-819.

32.

Potter

Schafer

Gonzalez-Mendez

Gjeltema

Lopez

Croughan-Minihane

(2001). Opioids for chronic nonmalignant pain: Attitudes and practices of primary care physicians in the UCSF/Stanford collaborative research network. Journal of Family Practice, 50, 145-151.

33.

Rehm

Frick

Hartwig

Gutzwiller

Gschwend

Uchtenhagen

(2005). Mortality in heroin-assisted treatment in Switzerland 1994-2000. Drug and Alcohol Dependence, 79, 137-143.

34.

Substance Abuse and Mental Health Services Administration. (1996). National Household Survey on Drug Abuse. Advance Report #18. Rockville, MD: Author. Retrieved from http://www.oas.samhsa.gov/nhsda/ar18ttoc.htm

35.

Substance Abuse and Mental Health Services Administration. (2002). National Survey on Drug Use and Health, 2002 (U.S. Department of Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies). Ann Arbor, MI: Inter-university Consortium for Political and Social Research. doi:10.3886/ICPSR03903

36.

Substance Abuse and Mental Health Services Administration. (2007). Results from the 2006 National Survey on Drug Use and Health: National findings. Retrieved from http://www.oas.samhsa.gov/nsduh/2k6nsduh/2k6results.pdf

37.

Substance Abuse and Mental Health Services Administration. (2009). National Survey on Drug Use and Health, 2007 (U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies). Ann Arbor, MI: Inter-university Consortium for Political and Social Research. doi:10.3886/ICPSR23782

38.

Substance Abuse and Mental Health Services Administration. (2012). Results from the 2011 National Survey on Drug Use and Health: Summary of national findings (NSDUH Series H-44, HHS Publication No. [SMA] 12-4713). Rockville, MD: Author.

39.

Sterman

J. D.

(2000). Business dynamics: Systems thinking and modeling for a complex world. Boston, MA: McGraw-Hill.

40.

Sterman

J. D.

(2006). Learning from evidence in a complex world. American Journal of Public Health, 96, 505-514.

41.

Sullivan

(2007, April). Epidemiology of chronic non-cancer pain and its treatment with opioids. Retrieved from archives.drugabuse.gov/meetings/painopioides/pdf/sullivan.pdf

42.

Warner

Chen

L. H.

Makuc

D. M.

(2009). Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006 (NCHS Data Brief, No. 22). Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. Retrieved from http://www.cdc.gov/nchs/data/databriefs/db22.pdf

43.

Warner

Chen

L. H.

Makuc

D. M.

Anderson

R. N.

Miniño

A. M.

(2011). Drug poisoning deaths in the United States, 1980-2008 (NCHS Data Brief, No. 81). Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. Retrieved from http://www.cdc.gov/nchs/data/databriefs/db81.pdf

44.

Warner-Smith

Lynskey

Darke

Hall

(2000). Heroin overdose: Prevalence, correlates, consequences, and interventions (Monograph No. 46). National Drug and Alcohol Research Centre, University of South Wales. Retrieved from http://www.med.unsw.edu.au/NDARCWeb.nsf/resources/Mono_6/$file/Mono.46.PDF

45.

Wakeland

Fitzgerald

Gilson

Haddox

J. D.

Homer

Lee

Webster

(2010). Key data gaps for understanding trends in prescription opioid analgesic abuse and diversion among chronic pain patients and nonmedical users. Poster presentation at College on Problems of Drug Dependence, 72nd Annual Scientific Meeting, Scottsdale, AZ.

46.

Wolfert

M. Z.

Gilson

A. M.

Dahl

J. L.

Cleary

J. F.

(2010). Opioid analgesics for pain control: Wisconsin physicians’ knowledge, beliefs, attitudes, and prescribing practices. Pain Medicine, 11, 425-434.